Dr. Gabriel Pardo helped develop the new multiple sclerosis medication Kesimpta and spoke about the drug.
Bodywork: Pressing pause on a coronavirus vaccine trial
Last week, the drug company AstraZeneca halted its SARS-CoV-2 vaccine trial. What happened?
Dry eyes, mouth? Patients needed for Sjögren’s syndrome studies at OMRF
OMRF is recruiting those who have or who think they may have Sjögren’s syndrome to participate in new research studies and a clinical trial.
START Coalition to bring comprehensive approach to opening communities safely
Oklahoma City will be site of the nonprofit alliance’s first major program roll out.
Business of Health: This is why we need clinical trials
Desperate times call for desperate measures.
An OMRF employee finds a new lease on life—at work
In MS, immune cells attack the protective covering of nerves in the brain, causing vision problems, tremors, paralysis, painful spasms, imbalance and cognitive changes.